Alt-711 - Cas: 341028-37-3, C13h14clnos | Advanced Glycation Endproduct Reversal For Cardiovascular Health
Price:
Get Latest Price
In Stock
Product Overview
Key Features
CAS: 341028-37-3
Molecular formula:C13H14ClNOS
Molecular weight:267.77
Alagebrium (formerly known as ALT-711) was a drug candidate developed by Alteon Corporation. It was the first drug candidate to be clinically tested for the purpose of breaking the crosslinks caused by advanced glycation endproducts (AGEs), thereby reversing one of the main mechanisms of aging. Through this effect Alagebrium is designed to reverse the stiffening of blood vessel walls that contributes to hypertension and cardiovascular disease, as well as many other forms of degradation associated with protein crosslinking. Alagebrium has proven effective in reducing systolic blood pressure and providing therapeutic benefit for patients with diastolic heart failure. Clients can avail this ALT-711 at industry leading prices from us.
Disclaimer
Company Details
Focusing on a customer-centric approach, Italy Delta Technology Co., Ltd. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Chemicals in bulk from Italy Delta Technology Co., Ltd. at Trade India quality-assured products.
Business Type
Exporter, Manufacturer
Related Products
Seller Details
Xuzhou, Jiangsu
Ms. Julienas
Address
weiyi road 133, Xuzhou, Jiangsu, 221000, China
Pharmaceutical Chemicals in Xuzhou
Report incorrect details